Arcturus Therapeutics Holdings (ARCT) Receivables - Other (2018 - 2026)

Arcturus Therapeutics Holdings has reported Receivables - Other for 9 years, with the latest figure at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other fell 90.78% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (down 90.78% YoY), and the FY2025 full-year result was $5.6 million, up 40.01% from the prior year.
• Receivables - Other for Q1 2026 stood at $1.3 million, down from $5.6 million in the prior quarter.
• The five-year high for Receivables - Other was $92.5 million in Q1 2023, with the low at $1.3 million in Q1 2026.
• Historically, Receivables - Other has averaged $18.1 million across 5 years, with a median of $8.0 million in 2025.
• Annual changes were most pronounced in 2023 — Receivables - Other jumped 2405.64% — and 2026, when it sank 90.78%.
• Arcturus Therapeutics Holdings' Receivables - Other stood at $2.8 million in 2022, then surged by 1060.06% to $32.1 million in 2023, then plunged by 87.61% to $4.0 million in 2024, then soared by 40.01% to $5.6 million in 2025, then plunged by 75.86% to $1.3 million in 2026.
• The last three Receivables - Other figures came in at $1.3 million (Q1 2026), $5.6 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.